Furthermore, increased levels of cleaved caspase-1 were identified in AD patient brains compared with controls in hippocampal and cortical lysates, implicating the NLRP3 inflammasome as an important pathway in disease (Heneka et al., 2013). This evidence concerns the gene CASP1 and Alzheimer disease.